Screening of Serum Autoantibodies to Cardiac β 1 -adrenoceptors and M 2 -muscarinic Acetylcholine Receptors in 408 Healthy Subjects of Varying Ages
Authors:
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 29 (1) , 43-51
Abstract
Autoantibodies to cardiac β1-adrenoceptors and M2-muscarinic receptors have mainly been found in the sera of patients with idiopathic dilated cardiomyopathy (DCM). In order to elucidate the pathological significance of these autoantibodies in DCM, it is necessary to understand their characteristic distribution in a healthy population of different genders and ages. The peptides corresponding to the sequences of the second extracellular loops of the human β1-adrenoceptor and M2-muscarinic receptors were therefore used as antigens to screen the sera of 408 healthy subjects of different ages (ranging from 0.5 to 85 years). Of 408 sera, 41 (10.0%) and 46 (11.3%) recognized the β1-adrenoceptor and M2-muscarinic receptor peptides respectively. Of the positive sera for β1-adrenoceptors and M2-muscarinic receptors, up to 63.4% and 56.5% had both anti-β1-adrenoceptor and anti-M2-muscarinic receptor autoantibodies respectively. The antibody titres of the positive sera of healthy subjects were all of a low level, with a geometric mean titre of 1:42 ± 1.9 for anti-β1-adrenoceptor antibodies and 1:51 ± 1.7 for anti-M2-muscarinic receptor antibodies. The frequency of occurrence of autoantibodies to both receptors in the sera of healthy subjects increased significantly with age. In conclusion, the autoantibodies to β1-adrenoceptors and M2-muscarinic receptors in the sera of healthy subjects are characterized by a low frequency of occurrence and low titre, with the frequency of occurrence increasing with age.Keywords
This publication has 12 references indexed in Scilit:
- Effects of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic acetylcholine receptors on transmembrane potentials and currents in guinea pig ventricular myocytesMolecular and Cellular Biochemistry, 1996
- Dilated Cardiomyopathy Defines Serum Autoantibodies Against G-Protein-Coupled Cardiovascular ReceptorsAutoimmunity, 1995
- Anti-β1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loopsJournal of Molecular and Cellular Cardiology, 1995
- Autoantibodies against Cardiac G-Protein-Coupled Receptors Define Different Populations with Cardiomyopathies but Not with HypertensionClinical Immunology and Immunopathology, 1994
- Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.Journal of Clinical Investigation, 1993
- Enzyme immunoassay techniques an overviewJournal of Immunological Methods, 1992
- Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.Journal of Clinical Investigation, 1990
- Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.Circulation Research, 1989
- Natural autoantibodies might prevent autoimmune diseaseImmunology Today, 1986
- Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.Heart, 1980